Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial (vol 7, pg 1225, 2021)

被引：0
|
作者：
Moxley, Katherine M.
George, Sagila
机构：
来源：
JAMA ONCOLOGY | 2022年
关键词：
D O I：
10.1001/jamaoncol.2022.1721
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH)
    Wang, Yaqi
    Shen, Lijun
    Wan, Juefeng
    Zhang, Hui
    Wu, Ruiyan
    Wang, Jingwen
    Wang, Yan
    Xu, Ye
    Cai, Sanjun
    Zhang, Zhen
    Xia, Fan
    BMC CANCER, 2022, 22 (01)
  • [22] Long-term results from NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC).
    George, Thomas J.
    Yothers, Greg
    Rahma, Osama E.
    Hong, Theodore S.
    Russell, Marcia McGory
    You, Y. Nancy
    Parker, William
    Jacobs, Samuel A.
    Lucas, Peter C.
    Colangelo, Linda H.
    Gollub, Marc J.
    Hall, William A.
    Kachnic, Lisa A.
    Bajaj, Madhuri
    Gross, Howard M.
    Peterson, Richard A.
    Dorth, Jennifer Anne
    Vijayvergia, Namrata
    Wolmark, Norman
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 7 - 7
  • [23] Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)
    Xia, Fan
    Wang, Yaqi
    Wang, Hui
    Shen, Lijun
    Xiang, Zuolin
    Zhao, Yutian
    Zhang, Huojun
    Wan, Juefeng
    Zhang, Hui
    Wang, Yan
    Wu, Ruiyan
    Wang, Jingwen
    Yang, Wang
    Zhou, Menglong
    Zhou, Shujuan
    Chen, Yajie
    Zhang, Zhiyuan
    Wu, Xian
    Xuan, Yan
    Wang, Renjie
    Sun, Yiqun
    Tong, Tong
    Zhang, Xun
    Wang, Lei
    Huang, Dan
    Sheng, Weiqi
    Yan, Hao
    Yang, Xu
    Shen, Yuxin
    Xu, Yu
    Zhao, Ruping
    Mo, Miao
    Cai, Guoxiang
    Cai, Sanjun
    Xu, Ye
    Zhang, Zhen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (28)
  • [24] The DUREC trial: Durvalumab plus total neoadjuvant therapy in locally advanced rectal cancer - a multicenter, single-arm, phase II study (GEMCAD-1703)
    Capdevila Castillon, J.
    Alonso, V.
    Macias Declara, I.
    Melian, M.
    Gallego Plazas, J.
    Vera, R.
    Riesco Martinez, M. C.
    Maurel, J.
    Grana Suarez, B.
    Hernando, J.
    Garcia Alvarez, A.
    Navalpotro, B.
    Soler Gonzalez, G.
    Polo, E.
    Garcia Fadrique, A.
    Espin, E.
    Fernandez Martos, C.
    Villacampa Javierre, G.
    Losa, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S430 - S431
  • [25] A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma
    Shi, Jin-Ming
    Li, Ning
    Jiang, Li-Ming
    Yang, Lin
    Wang, Shu-Lian
    Song, Yong-Wen
    Liu, Yue-Ping
    Fang, Hui
    Lu, Ning-Ning
    Qi, Shu-Nan
    Chen, Bo
    Li, Ye-Xiong
    Zhao, Dong-Bing
    Tang, Yuan
    Jin, Jing
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [26] Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial.
    Conroy, Thierry
    Etienne, Pierre-Luc
    Rio, Emmanuel
    Evesque, Ludovic
    Mesgouez-Nebout, Nathalie
    Vendrely, Veronique
    Artignan, Xavier
    Bouche, Olivier
    Boileve, Alice
    Delaye, Matthieu
    Gargot, Dany
    Boige, Valerie
    Bonichon-Lamichhane, Nathalie
    Louvet, Christophe
    De La Fouchardiere, Christelle
    Morand, Clotilde
    Pezzella, Veronica
    Rullier, Eric
    Castan, Florence
    Borg, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17_SUPPL) : LBA3504 - LBA3504
  • [27] Comparison of two different neoadjuvant chemoradiatiotherapy regimens for locally advanced rectal cancer: Results of a phase II, multicenter, randomized trial.
    Zhu, Ji
    Guan, Yun
    Yan, Senxiang
    Xu, Ye
    Li, Xinxiang
    Cai, Sanjun
    Zhang, Zhen
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Short-course radiotherapy combined with CAPOX and toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: Preliminary findings from a randomized, prospective, multicenter, double-arm, phase II trial (TORCH).
    Wang, Yaqi
    Xia, Fan
    Shen, Lijun
    Wan, Juefeng
    Zhang, Hui
    Wu, Ruiyan
    Wang, Jingwen
    Wang, Yan
    Xu, Ye
    Cai, Sanjun
    Zhang, Zhen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15602 - E15602
  • [29] Short-Course Radiotherapy Based Total Neoadjuvant Therapy Combined with Toripalimab for Locally Advanced Rectal Cancer: Preliminary Findings from a Randomized, Prospective, Multicenter, Double-Arm, Phase II Trial (TORCH)
    Wang, Y.
    Xia, F.
    Shen, L.
    Wan, J.
    Zhang, H.
    Wu, R.
    Wang, J.
    Wang, Y.
    Xu, Y.
    Cai, S.
    Zhang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E152 - E152
  • [30] Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: Long-term Results of a Prospective Phase II Study
    De Felice, F.
    Archetti, L.
    D'Ambrosio, G.
    Iafrate, F.
    Picone, V.
    Magliocca, F. M.
    Musio, D.
    Roberto, M.
    Casella, G.
    Clementi, I.
    Bulzonetti, N.
    Picchetto, A.
    Vitti, E.
    Merenda, E.
    Gentili, C.
    Lanzilao, M.
    Miccini, M.
    Illuminati, G.
    Delle Donne, A.
    Crocetti, D.
    Minozzi, M.
    Mongardini, M.
    Caronna, R.
    Fiori, E.
    Cortesi, E.
    CLINICAL ONCOLOGY, 2025, 37
12345